【発明の名称】生体還元性細胞傷害剤 - Shionogi Bioresearch Corporation

Title:

【発明の名称】生体還元性細胞傷害剤

Document Type and Number:

Japanese Patent JP2002516304

Kind Code:

A

Abstract:

A compound which consists of a proactive alkylating moiety containing an electron-withdrawing group, a bioreductive moiety containing at least two double bonds, and a linker joining the proactive alkylating moiety and the bioreductive moiety.

More Like This:

JP2001502676	INDUSTRIAL APPLICABILITY A preparation for transporting an active ingredient through a barrier.
JP5650684	Composition for water-containing external patch and patch using this composition
WO/2021/214033	VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL DISEASES

Inventors:

Ono, Mitsunori
Koya, Keizo
Sun, Rejoon
Wada, Yumiko
Urona, Wodichi etch
Dales, Natalie
Tao, Cerian
Holden, Sylvia

Application Number:

JP2000550818A

Publication Date:

June 04, 2002

Filing Date:

May 20, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Shionogi Bioresearch Corporation

International Classes:

A61K31/196; A61K31/235; A61K31/343; A61K31/403; A61K31/404; A61K31/4184; A61K31/5355; A61K31/5375; A61P35/00; A61P43/00; C07C37/02; C07C50/02; C07C229/56; C07C229/60; C07C229/64; C07C229/66; C07D295/08; C07C233/54; C07C271/28; C07D209/04; C07D209/08; C07D209/12; C07D235/02; C07D235/12; C07D235/16; C07D265/30; C07D295/10; C07D307/02; C07D307/42; C07D307/79; C07C; (IPC1-7): C07C229/64; A61K31/235; A61K31/343; A61K31/404; A61K31/4184; A61K31/5375; A61P35/00; A61P43/00; C07C229/56; C07C229/60; C07C233/54; C07C271/28; C07D209/08; C07D209/12; C07D235/16; C07D295/08; C07D307/79

Attorney, Agent or Firm:

Takehiko Suzue (4 outside)

Previous Patent: ガン、関節炎および網膜症を処置するための抗血管形成薬

Next Patent: インスリン抵抗性および高血糖症の治療に有用な２，３，５−置換ビフェ�...